Puccini, Alberto

CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - a target for novel cancer therapy

Tokunaga, R., Zhang, W., Naseem, M., Puccini, A., Berger, M. D., Soni, S., McSkane, M., Baba, H., & Lenz, H.-J. (2018) · Cancer Treatment Reviews

Chemokine receptors and signalingCancer Immunotherapy and Biomarkers

Cited by 1,627

Targeting the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Colorectal Cancer

Catalano, F., Borea, R., Puglisi, S., Boutros, A., Gandini, A., Cremante, M., Martelli, V., Sciallero, S., & Puccini, A. (2022) · Cancers

PARP inhibition in cancer therapyGenetic factors in colorectal cancer

Cited by 44

The role of immunotherapy in microsatellites stable metastatic colorectal cancer: State of the art and future perspectives

Gandini, A., Puglisi, S., Pirrone, C., Martelli, V., Catalano, F., Nardin, S., Seeber, A., Puccini, A., & Sciallero, S. (2023) · Frontiers in Oncology

Colorectal Cancer Treatments and StudiesCancer Immunotherapy and Biomarkers

Cited by 42

O-3 Characterization of KRAS mutation variants and prevalence of KRAS-G12C in gastrointestinal malignancies

Salem, M., El-Refai, S., Sha, W., Grothey, A., Puccini, A., George, T., Hwang, J., Kadakia, K., Musselwhite, L., Van Cutsem, E., et al. (2021) · Annals of Oncology

Cancer Genomics and DiagnosticsGastrointestinal Tumor Research and Treatment

Cited by 26

Redefining Colorectal Cancer by Tumor Biology

Salem, M. E., Puccini, A., & Tie, J. (2020) · American Society of Clinical Oncology Educational Book

Colorectal Cancer Treatments and StudiesGenetic factors in colorectal cancer

Cited by 14